Brief: Alphamab Oncology Resolved To Repurchase Ordinary Shares Up To HK$50 Mln In Value
15/08/2024 15:37
Aug 15 (Reuters) - Alphamab Oncology 9966.HK :
* RESOLVED TO REPURCHASE ORDINARY SHARES IN OPEN MARKET FROM
TIME
TO TIME UP TO HK$50 MILLION IN VALUE
Further company coverage: 9966.HK
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)